A growing body of evidence has demonstrated that serum cystatin C (CysC), albumin, and plasma/urine neutrophil gelatinase-associated lipocalin (NGAL) are valuable early diagnostic biomarkers for AKI [9,10,11]. Here, LCN2 is linked to acute kidney injury.